Medication package inserts’ usefulness for Sudanese pharmacists and patients: pharmacists’ perspective
Keywords:
Information, Package inserts medication, Patients, Pharmacists usefulnessAbstract
Background: Written medication information is important to health care professionals and patients, alike. Medication package inserts (PI) can prove useful sources for written medication information for pharmacist and patients. The main objective of this study was to evaluate the knowledge, attitude, and practice of the Sudanese pharmacists toward PIs.
Methods: A total of 120 randomly selected Sudanese community and hospital pharmacists, were addressed with a questionnaire of 14 free to answer closed-ended questions.
Results: Results showed clear dominance of the young (96.5%), females (63.3%)pharmacists population, whose majority (90.8%) had their undergraduates studies in Sudan. Majority (79.2%) of respondents was keen to read the PIs, and (75.8%)considered them as reliable written medication information sources and references. Correlation between respondents’ reliability and reading of PIs was significant (**p=0.038). How to use medications (95%) their dose (92.5%), and compliance (67.5%), topped the medication information particulars provided by respondents to patients. Drug-interactions and side-effects (36.7%) were downplayed by the respondents. Only a small minority (21.7%) of respondents used to advise patients to read PIs. Majority (85%) of respondents believed that PIs were difficult for patients to understand. Their texts’ language (68.2%), technical terminology (75%) and font size (10%) were cited as main barriers to understandability.
Conclusions: To secure usefulness of PIs, they shall be written in lay terminology of patients’ native language. Pharmacists shall seek independent sources of medication information, advice and motivate patients to read PIs and keep them for ongoing reference.
References
American Medical Association (AMA). Guidelines for physicians for counseling patients about prescription medications in the ambulatory setting, Reprinted 2004; 2011. Available from: http://www.talkaboutrx.org/documents/ama_guidelines.pdf. [Last cited on 2011 Mar 03].
Shrank W, Avorn J, Rolon C, Shekelle P. Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review. Ann Pharmacother. 2007;41(5):783-801.
Tebbi CK. Treatment compliance in childhood and adolescence. Cancer. 1993;71 10 Suppl:3441-9.
Cheraghali AM, Idries AM. Availability, affordability, and prescribing pattern of medicines in Sudan. Pharm World Sci. 2009;31(2):209-15.
Mai A, Aslani P. Impact of Vietnamese written and verbal medicine information on Vietnamese-speaking Australians’ knowledge and satisfaction. Br J Clin Pharmacol. 2007;64(4):527-35.
Sawalha A, Sweileh W, Zyoud Sh, Jabi S. Comparative analysis of patient package inserts of local and imported anti-infective agents in palestine. Libyan J Med. 2008;3(4):181-5.
Pharmaceuticals Statistical Report. Khartoum: Sudan Currency Press Printers Company Ltd.; 2007. p. 42.
Jaradat N, Sweileh WA. A descriptive study of community pharmacy practice in Palestine: analysis and future look. Al-Najah Univ J Res. 2003;17(2):191-9.
Ball DE, Al-Othman F. Drug information resources at private community pharmacies in Kuwait. Med Princ Pract. 2007;16(2):107-9.
Diobi K, Fakeye TO, Adisa R. Community pharmacists’ perception of the relevance of drug package insert as a source of drug information in southeastern Nigeria. Trop J Pharma Res. 2013;1293:439-43.
Adepu R, Nagavi BG. Attitudes and behaviors of practicing community pharmacists towards patient counselling. Indian J Pharm Sci. 2009;71(3):285-9.
Vinker S, Eliyahu V, Yaphe J. The effect of drug information leaflets on patient behavior. Isr Med Assoc J. 2007;9(5):383-6.
Carrigan N, Raynor DK, Knapp P. Adequacy of patient information on adverse effects: an assessment of patient information leaflets in the UK. Drug Saf. 2008;31(4):305-12.
Matt PH, Klaassen R. Side effects of side effects information in drug information leaflet. J Tech Writ Commun. 1994;24(4):389-404.
Petersen EE, Rasmussen SA, Daniel KL, Yazdy MM, Honein MA. Prescription medication borrowing and sharing among women of reproductive age. J Womens Health (Larchmt). 2008;17:1073-80.
Horwitz A, Reuther L, Andersen SE. Patient information leaflets seen through the eyes of patients in a general practice. Ugeskr Laeger. 2009;171(8):599-602.
Keith A. The benefits of pharmaceuticals promotion: an economic and health perspective. In: Pathak DS, Escovitz A, Kucukarslan S, editors. Promotion of Pharmaceuticals Issues Trends, Options. Binghamton: The Haworth Press; 1992. p. 121-33.
Glenton C. Developing patient-centred information for back pain sufferers. Health Expect. 2002;5(4):319-29.
European Commission (EC). A Guideline on the Readability of the Labeling and Package Leaflet of Medicinal Products for Human Use. Brussels; 2009. p. 7-10.
Wallace LS, Lennon ES. American Academy of Family Physicians patient education materials: can patients read them? Fam Med. 2004;36(8):571-4.
Avorn J, Shrank W. Highlights and a hidden hazard - The FDA’s new labeling regulations. N Engl J Med. 2006;354(23):2409-11.
Jeetu G, Girish T. Prescription drug labeling medication errors: a big deal for pharmacists. J Young Pharm. 2010;2(1):107-11.
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004 3;329(7456):15-9.
Lamb GC, Green SS, Heron J. Can physicians warn patients of potential side effects without fear of causing those side effects? Arch Intern Med. 1994;154(23):2753-6.
Nair K, Dolovich L, Cassels A, McCormack J, Levine M, Gray J, et al. What patients want to know about their medications. Focus group study of patient and clinician perspectives. Can Fam Physician. 2002;48:104-10.
